Mirati Therapeutics
MRTX
#2965
Rank
S$5.41 B
Marketcap
$77.20
Share price
0.00%
Change (1 day)
43.75%
Change (1 year)

EPS for Mirati Therapeutics (MRTX)

EPS in 2023 (TTM): -$17.47

According to Mirati Therapeutics's latest financial reports the company's current EPS (TTM) is -$16.86. In 2022 the company made an earnings per share (EPS) of -$17.33 a decrease over its 2021 EPS that were of -$14.69.

EPS history for Mirati Therapeutics from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$17.470.81%
2022-$17.3317.99%
2021-$14.6940.5%
2020-$10.4640.96%
2019-$7.4277.92%
2018-$4.1713.62%
2017-$3.67-33.57%
2016-$5.5210.82%
2015-$4.9816.98%
2014-$4.26-32.19%
2013-$6.2868.77%
2012-$3.72-15.95%
2011-$4.43-81.27%
2010-$23.65-37.19%
2009-$37.65174.53%
2008-$13.71-65.27%
2007-$39.49146.72%
2006-$16.00-58.81%
2005-$38.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$12.52-174.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.07891-99.53% Bahamas